Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Inside the Lab

Inside the Lab Laboratory management

What Do You Know About CQI?

| Cate Wight

A new initiative, Continuous Quality Improvement Awareness Month, aims to help pathologists get on board with CQI

Inside the Lab Clinical care

Under Pressure

| Will Culliford

How can diagnostic technologies help ease the increased healthcare pressures of the winter months?

Inside the Lab Digital and computational pathology

A Field in Transition

| Luke Turner

Discover the latest in the field of computational pathology and artificial intelligence

Inside the Lab Precision medicine

Next-Generation Sequencing: Will It Really Replace Single-Gene Tests in Pathology Labs?

| Sponsored by Thermo Fisher Scientific

The move to in-house next-generation sequencing has resulted in time and tissue savings, and improved collaboration across cancer care specialties

Inside the Lab Digital and computational pathology

A Real PAIGE-Turner

| Luke Turner

Paige.AI is developing deep learning algorithms to revolutionize cancer diagnostics

Inside the Lab Digital and computational pathology

Open to the Future

| Jane Rendall

If artificial intelligence is to make inroads into diagnostic medicine, we must embrace a new standard of openness and interoperability

Inside the Lab Digital and computational pathology

Leading by Example

| Michael Schubert

Bethany Williams shares her experiences as the world’s first Leadership and Management Fellow in Digital Pathology

Inside the Lab Clinical care

Positive Steps to Tackle Triple-Negative Breast Cancer

| Jane Armes

Jane Armes discusses the value of molecular subtyping and targeted therapies in triple-negative breast cancer

Inside the Lab Biochemistry and molecular biology

A Fluid Future

| Luke Turner

Liquid biopsy has shown promise as a rapid, minimally invasive way to profile tumors – but are commercially available tests accurate and consistent?

Inside the Lab Liquid biopsy

Building a Better Biopsy

| Lisa M. Wright

To harness liquid biopsy’s many advantages, it’s vital to ensure appropriate testing – and cfDNA synthetic plasma reference standards can help

Newsletter

Send me the latest from The Pathologist.

Sign up now

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register